Daniel Ciccarone1. 1. Department of Family and Community Medicine, University of California, San Francisco, California, USA.
Abstract
PURPOSE OF REVIEW: This review provides an update on recently published literature on the rise of illicit fentanyls, risks for overdose, combinations with other substances, e.g. stimulants, consequences, and treatment. RECENT FINDINGS: Overdose due to illicit synthetic opioids (e.g. fentanyl and fentanyl analogs) continues to rise in the US both preceding and during the COVID-19 pandemic. Fentanyl-related overdose is rising in new geographic areas e.g. the western USA. Stimulant-related overdose is also increasing nationwide driven by methamphetamine and cocaine. Polysubstance use, e.g. the use of a stimulant along with an opioid is driving stimulant-related overdose. Other medical consequences of injection drug use are rising including HIV and hepatitis C infections. Medication approaches to treating opioid use disorder remain the standard of care and there are new promising pharmacological approaches to treating methamphetamine use disorder. SUMMARY: A 'fourth wave' of high mortality involving methamphetamine and cocaine use has been gathering force in the USA. Availability and use of illicit fentanyls are still the major drivers of overdose deaths and the current rise in stimulant-related deaths appears entwined with the ongoing opioid epidemic.
PURPOSE OF REVIEW: This review provides an update on recently published literature on the rise of illicit fentanyls, risks for overdose, combinations with other substances, e.g. stimulants, consequences, and treatment. RECENT FINDINGS: Overdose due to illicit synthetic opioids (e.g. fentanyl and fentanyl analogs) continues to rise in the US both preceding and during the COVID-19 pandemic. Fentanyl-related overdose is rising in new geographic areas e.g. the western USA. Stimulant-related overdose is also increasing nationwide driven by methamphetamine and cocaine. Polysubstance use, e.g. the use of a stimulant along with an opioid is driving stimulant-related overdose. Other medical consequences of injection drug use are rising including HIV and hepatitis C infections. Medication approaches to treating opioid use disorder remain the standard of care and there are new promising pharmacological approaches to treating methamphetamine use disorder. SUMMARY: A 'fourth wave' of high mortality involving methamphetamine and cocaine use has been gathering force in the USA. Availability and use of illicit fentanyls are still the major drivers of overdose deaths and the current rise in stimulant-related deaths appears entwined with the ongoing opioid epidemic.
Authors: Alyona Mazhnaya; Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Michael E Kilkenny; Susan G Sherman; Sean T Allen Journal: Subst Use Misuse Date: 2020-05-22 Impact factor: 2.164
Authors: Brendan Saloner; Emma E McGinty; Leo Beletsky; Ricky Bluthenthal; Chris Beyrer; Michael Botticelli; Susan G Sherman Journal: Public Health Rep Date: 2018 Nov/Dec Impact factor: 2.792
Authors: Daniel Ciccarone; George Jay Unick; Jenny K Cohen; Sarah G Mars; Daniel Rosenblum Journal: Drug Alcohol Depend Date: 2016-04-14 Impact factor: 4.492
Authors: Mark Servis; Scott M Fishman; Mark S Wallace; Stephen G Henry; Doug Ziedonis; Daniel Ciccarone; Kelly R Knight; Steven Shoptaw; Patrick Dowling; Jeffrey R Suchard; Shalini Shah; Naileshni Singh; Lynette C Cedarquist; Navid Alem; David J Copenhaver; Marjorie Westervelt; Brigham C Willis Journal: Pain Med Date: 2021-02-04 Impact factor: 3.750
Authors: Linda B Cottler; Bruce A Goldberger; Sara Jo Nixon; Catherine W Striley; Elan Barenholtz; Nicole D Fitzgerald; Sean M Taylor; Joseph J Palamar Journal: Drug Alcohol Depend Date: 2020-09-14 Impact factor: 4.492
Authors: Ryan McNeil; Taylor Fleming; Samara Mayer; Allison Barker; Manal Mansoor; Alex Betsos; Tamar Austin; Sylvia Parusel; Andrew Ivsins; Jade Boyd Journal: Am J Public Health Date: 2022-03-09 Impact factor: 9.308
Authors: Xiao Zang; Alexandria Macmadu; Maxwell S Krieger; Czarina N Behrends; Traci C Green; Jake R Morgan; Sean M Murphy; Shayla Nolen; Alexander Y Walley; Bruce R Schackman; Brandon Dl Marshall Journal: Int J Drug Policy Date: 2021-09-03
Authors: Alexandria Macmadu; Lisa Frueh; Alexandra B Collins; Roxxanne Newman; Nancy P Barnett; Josiah D Rich; Melissa A Clark; Brandon D L Marshall Journal: Int J Drug Policy Date: 2022-07-08
Authors: David Goodman-Meza; Amber Tang; Babak Aryanfar; Sergio Vazquez; Adam J Gordon; Michihiko Goto; Matthew Bidwell Goetz; Steven Shoptaw; Alex A T Bui Journal: Open Forum Infect Dis Date: 2022-09-12 Impact factor: 4.423
Authors: Joseph J Palamar; Linda B Cottler; Bruce A Goldberger; Stevan Geoffrey Severtson; David J Grundy; Janetta L Iwanicki; Daniel Ciccarone Journal: Am J Drug Alcohol Abuse Date: 2022-06-15 Impact factor: 3.912